| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 13.47M | — |
| Operating expense | — | — |
| Net income | -78.76M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, OCUL returned -9.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -8.7% |
| 1 year | -9.9% |
| 5 years | +4.9% |
| 10 years | +73.4% |
| All-time high | $41.99 (Mar 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in OCUL would be worth today ›No. Ocular Therapeutix, Inc. has not paid a dividend in the past 12 months.
Ocular Therapeutix, Inc. stock trades on NASDAQ under the ticker symbol OCUL.
Ocular Therapeutix, Inc. is part of the Healthcare sector.
Ocular Therapeutix, Inc. has a market cap of 2.43B USD, based on the latest quote.
Ocular Therapeutix, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
